These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24507528)

  • 1. MRI outcomes in the diagnosis and disease course of multiple sclerosis.
    Simon JH
    Handb Clin Neurol; 2014; 122():405-25. PubMed ID: 24507528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI in multiple sclerosis.
    Simon JH
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):383-409, viii. PubMed ID: 15893678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
    Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R
    J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A
    Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on multiple sclerosis.
    Simon JH
    Radiol Clin North Am; 2006 Jan; 44(1):79-100, viii. PubMed ID: 16297683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H; Geurts JJ
    Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
    Filippi M; Agosta F
    Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in imaging of multiple sclerosis.
    Poloni G; Minagar A; Haacke EM; Zivadinov R
    Neurologist; 2011 Jul; 17(4):185-204. PubMed ID: 21712664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
    Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
    Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic criteria of multiple sclerosis in neuroimaging].
    Dupel-Pottier C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):949-62. PubMed ID: 11787360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI in multiple sclerosis: a review of the current literature.
    Ceccarelli A; Bakshi R; Neema M
    Curr Opin Neurol; 2012 Aug; 25(4):402-9. PubMed ID: 22691759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MRI in the diagnosis of multiple sclerosis.
    Traboulsee AL; Li DK
    Adv Neurol; 2006; 98():125-46. PubMed ID: 16400831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.
    Sbardella E; Tomassini V; Stromillo ML; Filippini N; Battaglini M; Ruggieri S; Ausili Cefaro L; Raz E; Gasperini C; Sormani MP; Pantano P; Pozzilli C; De Stefano N
    Mult Scler; 2011 Dec; 17(12):1432-40. PubMed ID: 21729978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relevance of Magnet Resonance Tomography in the Diagnosis and Assessment of Course of Disease in Patients with Multiple Sclerosis].
    Lukas C; Sailer M
    Fortschr Neurol Psychiatr; 2015 Sep; 83(9):522-32; quiz 533-4. PubMed ID: 26421860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.